Functional outcome and morbidity after microsurgical resection of spinal meningiomas.


Journal

Neurosurgical focus
ISSN: 1092-0684
Titre abrégé: Neurosurg Focus
Pays: United States
ID NLM: 100896471

Informations de publication

Date de publication:
05 2021
Historique:
received: 31 12 2020
accepted: 17 02 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 30 9 2021
Statut: ppublish

Résumé

The aim of this study was to evaluate functional outcome, surgical morbidity, and factors that affect outcomes of surgically treated patients. The authors retrospectively analyzed patients who underwent microsurgical resection for spinal meningiomas between 2009 and 2020. Patient data and potential variables were collected and evaluated consecutively. Functional outcomes were evaluated using univariate and multivariate analyses. A total of 119 patients underwent microsurgical resection of spinal meningioma within the study period. After a mean follow-up of 25.4 ± 37.1 months, the rates of overall complication, tumor recurrence, and poor functional outcome were 9.2%, 7.6%, and 5%, respectively. Age, sex, revision surgery, and tumor recurrence were identified as independent predictors of poor functional outcome. Obesity and surgeon's experience had an impact on the complication rate, whereas extent of resection and tumor calcification affected the rate of tumor recurrence. Microsurgical resection of spinal meningiomas remains safe. Nevertheless, some aspects, such as obesity and experience of the surgeons that result in a higher complication rate and ultimately affect clinical outcome, should be considered when performing surgery.

Identifiants

pubmed: 33932928
doi: 10.3171/2021.2.FOCUS201116
pii: 2021.2.FOCUS201116
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E20

Auteurs

Fatma Kilinc (F)

Departments of1Neurosurgery and.

Matthias Setzer (M)

Departments of1Neurosurgery and.

Gerhard Marquardt (G)

Departments of1Neurosurgery and.

Fee Keil (F)

2Neuroradiology, Goethe-University, Frankfurt am Main, Germany.

Daniel Dubinski (D)

Departments of1Neurosurgery and.

Markus Bruder (M)

Departments of1Neurosurgery and.

Volker Seifert (V)

Departments of1Neurosurgery and.

Bedjan Behmanesh (B)

Departments of1Neurosurgery and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH